An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging ...
Tumor necrosis factor-related apoptosis ... TRAIL-sensitive tumor cells in vitro along with perforin and Fas ligand (FasL). Administration of neutralizing monoclonal antibody against TRAIL ...
Because cancer cells have ... a chemical signal that causes that patch of membrane to be pinched off and sucked into the cell as a tiny bubble. The whole P-cadherin/antibody/drug complex is ...
Antibody-Drug Conjugate Found Effective Against Brain Metastases in Patients With HER2-Positive Breast Cancer ... Prostate apoptosis response-4 (Par-4) can cause a unique type of cell death ...
Peptide therapy enhances targeted medicine, utilizing specific peptides for effective treatment of cancer, metabolic disorders, and neurodegenerative diseases.
Multiple myeloma is a type of blood cancer that forms in plasma cells, white blood cells that produce infection-fighting antibodies ... DNA of plasma cells. What causes these genetic mutations ...
Clinical trials are in progress to see how this therapy might be able to treat other types of cancers, including solid tumors, which can be harder for CAR T-cells to reach. Monoclonal antibody ...
We investigated the apoptosis ... cells. Cytokine levels and host innate immune responses, including expression of interferon regulatory transcription factor (IRF)-3, signal transducer and activator ...
Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced additional follow-up ...
More research on how chemotherapy and patient-specific factors impact TAMs and cancer progression is needed to refine treatment strategies for cancer patients. Metastasis – the systemic spread of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results